Terms: = Cervical cancer AND TOP2A, TOP2, TP2A AND Treatment
6 results:
1. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase top2a expression.
Zhang J; Yu X; Guo Y; Wang D
Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
[TBL] [Abstract] [Full Text] [Related]
2. [Expression of ProEXC and PRMT5 in cervical adenocarcinoma and their clinical significance].
Cui HX; Lou XL; Xia W; Zhang YS; Cheng XY; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(48):3967-3971. PubMed ID: 38129175
[TBL] [Abstract] [Full Text] [Related]
3. Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
Andalib KMS; Rahman MH; Habib A
J Biomol Struct Dyn; 2023; 41(23):14232-14247. PubMed ID: 36852684
[TBL] [Abstract] [Full Text] [Related]
4. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for cervical cancer.
Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
[TBL] [Abstract] [Full Text] [Related]
5. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for cervical cancer: A Bioinformatics Analysis.
Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
[TBL] [Abstract] [Full Text] [Related]
6. Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
Wu DM; Shi J; Liu T; Deng SH; Han R; Xu Y
Cancer Biomark; 2018 Feb; 21(2):355-365. PubMed ID: 29103025
[TBL] [Abstract] [Full Text] [Related]
